This inventor holds 1 USPTO granted patent. Top assignee: Universiteit Gent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heleen Dewitte: Research in Therapeutic Nanoparticles
Introduction
Heleen Dewitte is an inventor based in Gentbrugge, Belgium, whose work includes research into nanoparticle-based delivery of nucleic acids. She is associated with Universiteit Gent and is named on one patent.
Latest Patents
Dewitte’s patent, “Therapeutic Nanoparticles and Methods of Use Thereof,” describes a composition and method designed to optimize intracellular delivery of nucleic acids, particularly mRNA. The nanoparticle composition may also include a glycolipid antigen, and the patent describes combinations with checkpoint inhibitors. The approach targets antigen-presenting cells and is intended for potential use in immunotherapy and vaccination.
Career Highlights
Dewitte’s listed patent activity reflects work at the intersection of nanotechnology and therapeutic delivery. Her record includes 1 patent, and she is associated with Universiteit Gent.
Collaborations
Her named coworkers include Rein Verbeke and Stefaan De Smedt, who are also associated with research in this field.
Conclusion
Heleen Dewitte’s patent highlights a nanoparticle-based approach to delivering mRNA and related components to antigen-presenting cells, with potential applications in immunotherapy and vaccination.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile